SERONO ENROLLING US PATIENTS TO ORAL MS DRUG TRIAL

A A

Serono is in a race with other companies, including Swiss peer Novartis AG (NVS), to bring the first oral MS drug to the market. Oral cladribine is also known under its suggested brand name Mylinax.

Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=886254&contentType=sentryarticle&channelID=30)